Equity Market Research
Wednesday, 3 May 2017
Alembic Pharma: In 4Q FY17, we expect Alembic post 27.1% YoY growth in reported sales to INR7.9b:MOSL https://goo.gl/sSqOLl
Alembic Pharma: In 4Q FY17, we expect Alembic post 27.1% YoY growth in reported sales to INR7.9b:MOSL https://goo.gl/sSqOLl
https://goo.gl/sSqOLl
No comments:
Post a Comment
‹
›
Home
View web version
No comments:
Post a Comment